Home > Archive>Volume 51, Issue 9, 2024 >3384-3397. DOI:10.13344/j.microbiol.china.231019
PDF HTML XML Export Cite reminder
Research progress of intestinal barrier and gut microbiota in ulcerative colitis
Author:
  • Article
    • | |
  • Metrics
    • |
  • Reference [83]
    • |
  • Related
    • | | |
  • Comments
    Abstract:

    Ulcerative colitis (UC) is an inflammatory bowel disease with unknown pathogenesis and increasing incidence. An intact intestinal barrier is essential for maintaining intestinal homeostasis and preventing diseases. The gut microbiota plays a crucial role in constituting the intestinal barrier, enhancing the immune response of the intestinal mucosa, and maintaining the intestinal environment. The gut microbiota imbalance can lead to intestinal barrier damage, and both intestinal barrier damage and gut microbiota imbalance are involved in the development of UC. In recent years, increasing studies of UC focused on the intestinal barrier and regulation of gut microbiota have been carried out. This article reviews the components of the intestinal barrier and the role of gut microbiota in UC, aiming to provide a theoretical basis for the future research in this field.

    Reference
    [1] ADAMS SM, CLOSE ED, SHREENATH AP. Ulcerative colitis: rapid evidence review[J]. American Family Physician, 2022, 105(4): 406-411.
    [2] DU L, HA C. Epidemiology and pathogenesis of ulcerative colitis[J]. Gastroenterology Clinics of North America, 2020, 49(4): 643-654.
    [3] COUFAL S, GALANOVA N, BAJER L, GAJDAROVA Z, SCHIEROVA D, ZAKOSTELSKA ZJ, KOSTOVCIKOVA K, JACKOVA Z, STEHLIKOVA Z, DRASTICH P, TLASKALOVA-HOGENOVA H, KVERKA M. Inflammatory bowel disease types differ in markers of inflammation, gut barrier and in specific anti-bacterial response[J]. Cells, 2019, 8(7): 719.
    [4] WEI SC, SOLLANO J, HUI YT, YU W, SANTOS ESTRELLA PV, LLAMADO LJQ, KORAM N. Epidemiology, burden of disease, and unmet needs in the treatment of ulcerative colitis in Asia[J]. Expert Review of Gastroenterology & Hepatology, 2021, 15(3): 275-289.
    [5] JESS T, GAMBORG M, MUNKHOLM P, SØRENSEN TIA. Overall and cause-specific mortality in ulcerative colitis: meta-analysis of population-based inception cohort studies[J]. The American Journal of Gastroenterology, 2007, 102(3): 609-617.
    [6] POPOV J, CAPUTI V, NANDEESHA N, RODRIGUEZ DA, PAI N. Microbiota-immune interactions in ulcerative colitis and colitis associated cancer and emerging microbiota-based therapies[J]. International Journal of Molecular Sciences, 2021, 22(21): 11365.
    [7] FARHADI A, BANAN A, FIELDS J, KESHAVARZIAN A. Intestinal barrier: an interface between health and disease[J]. Journal of Gastroenterology and Hepatology, 2003, 18(5): 479-497.
    [8] AN J, LIU YQ, WANG YQ, FAN R, HU XR, ZHANG F, YANG JH, CHEN JW. The role of intestinal mucosal barrier in autoimmune disease: a potential target[J]. Frontiers in Immunology, 2022, 13: 871713.
    [9] MARTEL J, CHANG SH, KO YF, HWANG TL, YOUNG JD, OJCIUS DM. Gut barrier disruption and chronic disease[J]. Trends in Endocrinology and Metabolism: TEM, 2022, 33(4): 247-265.
    [10] KOBOZIEV I, WEBB CR, FURR KL, GRISHAM MB. Role of the enteric microbiota in intestinal homeostasis and inflammation[J]. Free Radical Biology & Medicine, 2014, 68: 122-133.
    [11] BRODY H. The gut microbiome[J]. Nature, 2020, 577(7792): S5.
    [12] CHEN SS, ZHANG C, HE BH, HE RN, XU L, ZHANG S. The role of lncRNAs in regulating the intestinal mucosal mechanical barrier[J]. BioMed Research International, 2021, 2021: 2294942.
    [13] ZHENG L, DUAN SL. Molecular regulation mechanism of intestinal stem cells in mucosal injury and repair in ulcerative colitis[J]. World Journal of Gastroenterology, 2023, 29(16): 2380-2396.
    [14] ZHAO XJ, ZENG HL, LEI L, TONG XL, YANG L, YANG Y, LI S, ZHOU Y, LUO LP, HUANG JH, XIAO R, CHEN J, ZENG QH. Tight junctions and their regulation by non-coding RNAs[J]. International Journal of Biological Sciences, 2021, 17(3): 712-727.
    [15] SALVO-ROMERO E, ALONSO-COTONER C, PARDO-CAMACHO C, CASADO-BEDMAR M, VICARIO M. The intestinal barrier function and its involvement in digestive disease[J]. Revista Espanola De Enfermedades Digestivas, 2015, 107(11): 686-696.
    [16] RÜBSAM M, BROUSSARD JA, WICKSTRÖM SA, NEKRASOVA O, GREEN KJ, NIESSEN CM. Adherens junctions and desmosomes coordinate mechanics and signaling to orchestrate tissue morphogenesis and function: an evolutionary perspective[J]. Cold Spring Harbor Perspectives in Biology, 2018, 10(11): a029207.
    [17] TAN Y, GUAN YD, SUN Y, ZHENG CQ. Correlation of intestinal mucosal healing and tight junction protein expression in ulcerative colitis patients[J]. The American Journal of the Medical Sciences, 2019, 357(3): 195-204.
    [18] LI YY, WANG XJ, SU YL, WANG Q, HUANG SW, PAN ZF, CHEN YP, LIANG JJ, ZHANG ML, XIE XQ, WU ZY, CHEN JY, ZHOU L, LUO X. Baicalein ameliorates ulcerative colitis by improving intestinal epithelial barrier via AhR/IL-22 pathway in ILC3s[J]. Acta Pharmacologica Sinica, 2022, 43: 1495-1507.
    [19] CHEN HP, QIAN YF, JIANG CS, TANG LL, YU JW, ZHANG LD, DAI YY, JIANG GJ. Butyrate ameliorated ferroptosis in ulcerative colitis through modulating Nrf2/GPX4 signal pathway and improving intestinal barrier[J]. Biochimica et Biophysica Acta Molecular Basis of Disease, 2024, 1870(2): 166984.
    [20] PELASEYED T, BERGSTRÖM JH, GUSTAFSSON JK, ERMUND A, BIRCHENOUGH GMH, SCHÜTTE A, van der POST S, SVENSSON F, RODRÍGUEZ- PIÑEIRO AM, NYSTRÖM EEL, WISING C, JOHANSSON MEV, HANSSON GC. The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system[J]. Immunological Reviews, 2014, 260(1): 8-20.
    [21] PAONE P, CANI PD. Mucus barrier, mucins and gut microbiota: the expected slimy partners?[J]. Gut, 2020, 69(12): 2232-2243.
    [22] van der POST S, JABBAR KS, BIRCHENOUGH G, ARIKE L, AKHTAR N, SJOVALL H, JOHANSSON MEV, HANSSON GC. Structural weakening of the colonic mucus barrier is an early event in ulcerative colitis pathogenesis[J]. Gut, 2019, 68(12): 2142-2151.
    [23] van der SLUIS M, de KONING BAE, de BRUIJN ACJM, VELCICH A, MEIJERINK JPP, van GOUDOEVER JB, BÜLLER HA, DEKKER J, van SEUNINGEN I, RENES IB, EINERHAND AWC. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection[J]. Gastroenterology, 2006, 131(1): 117-129.
    [24] SÜNDERHAUF A, HICKEN M, SCHLICHTING H, SKIBBE K, RAGAB M, RASCHDORF A, HIROSE M, SCHÄFFLER H, BOKEMEYER A, BETTENWORTH D, SAVITT AG, PERNER S, IBRAHIM S, PEERSCHKE EI, GHEBREHIWET B, DERER S, SINA C. Loss of mucosal p32/gC1qR/HABP1 triggers energy deficiency and impairs goblet cell differentiation in ulcerative colitis[J]. Cellular and Molecular Gastroenterology and Hepatology, 2021, 12(1): 229-250.
    [25] ZHANG BW, ZHAO CY, ZHANG XJ, LI X, ZHANG YH, LIU XX, YIN J, LI XY, WANG J, WANG S. An elemental diet enriched in amino acids alters the gut microbial community and prevents colonic mucus degradation in mice with colitis[J]. mSystems, 2022, 7(6): e0088322.
    [26] GUBATAN J, HOLMAN DR, PUNTASECCA CJ, POLEVOI D, RUBIN SJ, ROGALLA S. Antimicrobial peptides and the gut microbiome in inflammatory bowel disease[J]. World Journal of Gastroenterology, 2021, 27(43): 7402-7422.
    [27] KOENINGER L, ARMBRUSTER NS, BRINCH KS, KJAERULF S, ANDERSEN B, LANGNAU C, AUTENRIETH SE, SCHNEIDAWIND D, STANGE EF, MALEK NP, NORDKILD P, JENSEN BAH, WEHKAMP J. Human β-defensin 2 mediated immune modulation as treatment for experimental colitis[J]. Frontiers in Immunology, 2020, 11: 93.
    [28] QUIROZ-OLGUÍN G, GUTIÉRREZ-SALMEÁN G, POSADAS-CALLEJA JG, PADILLA-RUBIO MF, SERRALDE-ZÚÑIGA AE. The effect of enteral stimulation on the immune response of the intestinal mucosa and its application in nutritional support[J]. European Journal of Clinical Nutrition, 2021, 75: 1533-1539.
    [29] MÖRBE UM, JØRGENSEN PB, FENTON TM, von BURG N, RIIS LB, SPENCER J, AGACE WW. Human gut-associated lymphoid tissues (GALT); diversity, structure, and function[J]. Mucosal Immunology, 2021, 14: 793-802.
    [30] LI Y, JIN L, CHEN TX. The effects of secretory IgA in the mucosal immune system[J]. BioMed Research International, 2020, 2020: 2032057.
    [31] HIYAMA S, IIJIMA H, KAWAI S, MUKAI A, SHIRAISHI E, IWATANI S, YAMAGUCHI T, ARAKI M, HAYASHI Y, SHINZAKI S, MIZUSHIMA T, TSUJII M, TAKEHARA T. Narrow-band imaging with magnifying endoscopy for Peyer’s patches is useful in predicting the recurrence of remissive patients with ulcerative colitis[J]. Intestinal Research, 2016, 14(4): 314-321.
    [32] OHNO H. Intestinal M cells[J]. The Journal of Biochemistry, 2016, 159(2): 151-160.
    [33] ROUND JL, MAZMANIAN SK. The gut microbiota shapes intestinal immune responses during health and disease[J]. Nature Reviews Immunology, 2009, 9: 313-323.
    [34] SCHOULTZ I, KEITA ÅV. Cellular and molecular therapeutic targets in inflammatory bowel disease-focusing on intestinal barrier function[J]. Cells, 2019, 8(2): 193.
    [35] NAKASE H, SATO N, MIZUNO N, IKAWA Y. The influence of cytokines on the complex pathology of ulcerative colitis[J]. Autoimmunity Reviews, 2022, 21(3): 103017.
    [36] PUGLIESE D, PRIVITERA G, FIORANI M, PARISIO L, CALVEZ V, PAPA A, GASBARRINI A, ARMUZZI A. Targeting IL12/23 in ulcerative colitis: update on the role of ustekinumab[J]. Therapeutic Advances in Gastroenterology, 2022, 15: 17562848221102283.
    [37] LI ZC, LIN ML, LI YD, SHAO J, HUANG RT, QIU YY, LIU Y, CHEN L. Total flavonoids of Sophora flavescens and kurarinone ameliorated ulcerative colitis by regulating Th17/Treg cell homeostasis[J]. Journal of Ethnopharmacology, 2022, 297: 115500.
    [38] GOMAA EZ. Human gut microbiota/microbiome in health and diseases: a review[J]. Antonie Van Leeuwenhoek, 2020, 113(12): 2019-2040.
    [39] ADAK A, KHAN MR. An insight into gut microbiota and its functionalities[J]. Cellular and Molecular Life Sciences, 2019, 76(3): 473-493.
    [40] ALMEIDA A, NAYFACH S, BOLAND M, STROZZI F, BERACOCHEA M, SHI ZJ, POLLARD KS, SAKHAROVA E, PARKS DH, HUGENHOLTZ P, SEGATA N, KYRPIDES NC, FINN RD. A unified catalog of 204, 938 reference genomes from the human gut microbiome[J]. Nature Biotechnology, 2021, 39(1): 105-114.
    [41] HORNEF M. Pathogens, commensal symbionts, and pathobionts: discovery and functional effects on the host[J]. ILAR Journal, 2015, 56(2): 159-162.
    [42] MA LY, SHEN QC, LYU WT, LV L, WANG W, YU MJ, YANG H, TAO SY, XIAO YP. Clostridium butyricum and its derived extracellular vesicles modulate gut homeostasis and ameliorate acute experimental colitis[J]. Microbiology Spectrum, 2022, 10(4): e0136822.
    [43] LIANG LP, LIU L, ZHOU WY, YANG CH, MAI GH, LI HL, CHEN Y. Gut microbiota-derived butyrate regulates gut mucus barrier repair by activating the macrophage/WNT/ERK signaling pathway[J]. Clinical Science, 2022, 136(4): 291-307.
    [44] ZUO WX, WANG BB, BAI X, LUAN YH, FAN YY, MICHAIL S, SUN FZ. 16S rRNA and metagenomic shotgun sequencing data revealed consistent patterns of gut microbiome signature in pediatric ulcerative colitis[J]. Scientific Reports, 2022, 12: 6421.
    [45] SHAM HP, BAZETT M, BOSILJCIC M, YANG H, LUK B, LAW HT, MORAMPUDI V, YU HB, PANKOVICH J, SUTCLIFFE S, BRESSLER B, MARSHALL JK, FEDORAK RN, CHEN J, JONES M, GUNN H, KALYAN S, VALLANCE BA. Immune stimulation using a gut microbe-based immunotherapy reduces disease pathology and improves barrier function in ulcerative colitis[J]. Frontiers in Immunology, 2018, 9: 2211.
    [46] YOO JY, GROER M, DUTRA SVO, SARKAR A, McSKIMMING DI. Gut microbiota and immune system interactions[J]. Microorganisms, 2020, 8(10): 1587.
    [47] VINDEROLA G, SANDERS ME, SALMINEN S. The concept of postbiotics[J]. Foods, 2022, 11(8): 1077.
    [48] YANG YF, WANG Y, ZHAO L, WANG F, LI MX, WANG Q, LUO HM, ZHAO QY, ZENG JP, ZHAO YS, DU FK, CHEN Y, SHEN J, WEI SL, XIAO ZG, WU X. Chinese herbal medicines for treating ulcerative colitis via regulating gut microbiota-intestinal immunity axis[J]. Chinese Herbal Medicines, 2023, 15(2): 181-200.
    [49] GUARINO MPL, ALTOMARE A, EMERENZIANI S, Di ROSA C, RIBOLSI M, BALESTRIERI P, IOVINO P, ROCCHI G, CICALA M. Mechanisms of action of prebiotics and their effects on gastro-intestinal disorders in adults[J]. Nutrients, 2020, 12(4): 1037.
    [50] VALCHEVA R, KOLEVA P, MARTÍNEZ I, WALTER J, GÄNZLE MG, DIELEMAN LA. Inulin-type fructans improve active ulcerative colitis associated with microbiota changes and increased short-chain fatty acids levels[J]. Gut Microbes, 2019, 10(3): 334-357.
    [51] HE NN, WANG YY, ZHOU ZH, LIU N, JUNG S, LEE MS, LI SY. Preventive and prebiotic effect of α-galacto-oligosaccharide against dextran sodium sulfate-induced colitis and gut microbiota dysbiosis in mice[J]. Journal of Agricultural and Food Chemistry, 2021, 69(33): 9597-9607.
    [52] NYMAN M, NGUYEN TD, WIKMAN O, HJORTSWANG H, HALLERT C. Oat bran increased fecal butyrate and prevented gastrointestinal symptoms in patients with quiescent ulcerative colitis: randomized controlled trial[J]. Crohn’s & Colitis 360, 2020, 2(1): otaa005.
    [53] SHEN ZH, ZHU CX, QUAN YS, YANG ZY, WU S, LUO WW, TAN B, WANG XY. Relationship between intestinal microbiota and ulcerative colitis: mechanisms and clinical application of probiotics and fecal microbiota transplantation[J]. World Journal of Gastroenterology, 2018, 24(1): 5-14.
    [54] KHAN I, WEI JS, LI AP, LIU ZR, YANG PR, JING YP, CHEN XJ, ZHAO T, BAI YR, ZHA LJ, LI CH, ULLAH N, CHE TJ, ZHANG CJ. Lactobacillus plantarum strains attenuated DSS-induced colitis in mice by modulating the gut microbiota and immune response[J]. International Microbiology, 2022, 25(3): 587-603.
    [55] HU YJ, JIN XL, GAO F, LIN T, ZHU H, HOU X, YIN Y, KAN SD, CHEN DJ. Selenium-enriched Bifidobacterium longum DD98 effectively ameliorates dextran sulfate sodium-induced ulcerative colitis in mice[J]. Frontiers in Microbiology, 2022, 13: 955112.
    [56] KAUR L, GORDON M, BAINES PA, IHEOZOR- EJIOFOR Z, SINOPOULOU V, AKOBENG AK. Probiotics for induction of remission in ulcerative colitis[J]. The Cochrane Database of Systematic Reviews, 2020, 3(3): CD005573.
    [57] RUFINO MN, Da COSTA AL, JORGE EN, PAIANO VF, CAMPAROTO ML, KELLER R, BREMER-NETO H. Synbiotics improve clinical indicators of ulcerative colitis: systematic review with meta-analysis[J]. Nutrition Reviews, 2022, 80(2): 157-164.
    [58] SWANSON KS, GIBSON GR, HUTKINS R, REIMER RA, REID G, VERBEKE K, SCOTT KP, HOLSCHER HD, AZAD MB, DELZENNE NM, SANDERS ME. The international scientific association for probiotics and prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics[J]. Nature Reviews Gastroenterology & Hepatology, 2020, 17: 687-701.
    [59] NGUYEN TT, NGUYEN PT, PHAM MN, RAZAFINDRALAMBO H, HOANG QK, NGUYEN HT. Synbiotics: a new route of self-production and applications to human and animal health[J]. Probiotics and Antimicrobial Proteins, 2022, 14(5): 980-993.
    [60] LIU ZZ, JIANG ZY, ZHANG ZT, LIU T, FAN YR, LIU T, PENG N. Bacillus coagulans in combination with chitooligosaccharides regulates gut microbiota and ameliorates the DSS-induced colitis in mice[J]. Microbiology Spectrum, 2022, 10(4): e0064122.
    [61] KAMARLı ALTUN H, AKAL YıLDıZ E, AKıN M. Effects of synbiotic therapy in mild-to-moderately active ulcerative colitis: a randomized placebo- controlled study[J]. The Turkish Journal of Gastroenterology, 2019, 30(4): 313-320.
    [62] SALMINEN S, COLLADO MC, ENDO A, HILL C, LEBEER S, QUIGLEY EMM, SANDERS ME, SHAMIR R, SWANN JR, SZAJEWSKA H, VINDEROLA G. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics[J]. Nature Reviews Gastroenterology & Hepatology, 2021, 18: 649-667.
    [63] CHEN QY, FAN YY, ZHANG BZ, YAN CS, ZHANG Q, KE YH, CHEN ZR, WANG L, SHI HX, HU YQ, HUANG QW, SU JL, XIE CX, ZHANG X, ZHOU LX, REN JL, XU HZ. Capsulized fecal microbiota transplantation induces remission in patients with ulcerative colitis by gut microbial colonization and metabolite regulation[J]. Microbiology Spectrum, 2023, 11(3): e0415222.
    [64] ZHANG LH, LIU JX, JIN T, QIN NB, REN XM, XIA XD. Live and pasteurized Akkermansia muciniphila attenuate hyperuricemia in mice through modulating uric acid metabolism, inflammation, and gut microbiota[J]. Food & Function, 2022, 13(23): 12412-12425.
    [65] WU YP, WANG Y, HU AX, SHU X, HUANG WX, LIU JS, WANG BK, ZHANG RQ, YUE M, YANG CM. Lactobacillus plantarum-derived postbiotics prevent Salmonella-induced neurological dysfunctions by modulating gut-brain axis in mice[J]. Frontiers in Nutrition, 2022, 9: 946096.
    [66] ŠTOFILOVÁ J, KVAKOVÁ M, KAMLÁROVÁ A, HIJOVÁ E, BERTKOVÁ I, GUĽAŠOVÁ Z. Probiotic-based intervention in the treatment of ulcerative colitis: conventional and new approaches[J]. Biomedicines, 2022, 10(9): 2236.
    [67] CHEN HT, HUANG HL, XU HM, LUO QL, HE J, LI YQ, ZHOU YL, NIE YQ, ZHOU YJ. Fecal microbiota transplantation ameliorates active ulcerative colitis[J]. Experimental and Therapeutic Medicine, 2020, 19(4): 2650-2660.
    [68] 张发明. 粪菌移植: 1700年的医学史及其临床应用[J]. 湖北民族学院学报(医学版), 2012, 29(3): 1-4. ZHANG FM. Fecal bacteria transplantation: 1700 years of medical history and its clinical application[J]. Journal of Hubei University Minzu University (Medical Edition), 2012, 29(3): 1-4(in Chinese).
    [69] HUANG CL, HUANG ZH, DING L, FU Y, FAN JJ, MEI QX, LOU LH, WANG JJ, YIN NM, LU YY, GUO SW, ZENG Y. Fecal microbiota transplantation versus glucocorticoids for the induction of remission in mild to moderate ulcerative colitis[J]. Journal of Translational Medicine, 2022, 20(1): 354.
    [70] WANG WH, LU GC, WU X, WEN Q, ZHANG FM. Colonic transendoscopic enteral tubing is a new pathway to microbial therapy, colonic drainage, and host-microbiota interaction research[J]. Journal of Clinical Medicine, 2023, 12(3): 780.
    [71] WEN X, WANG HG, ZHANG MN, ZHANG MH, WANG H, YANG XZ. Fecal microbiota transplantation ameliorates experimental colitis via gut microbiota and T-cell modulation[J]. World Journal of Gastroenterology, 2021, 27(21): 2834-2849.
    [72] LEDDER O. Antibiotics in inflammatory bowel diseases: do we know what we’re doing?[J]. Translational Pediatrics, 2019, 8(1): 42-55.
    [73] NISHIKAWA Y, SATO N, TSUKINAGA S, UCHIYAMA K, KOIDO S, ISHIKAWA D, OHKUSA T. Long-term outcomes of antibiotic combination therapy for ulcerative colitis[J]. Therapeutic Advances in Chronic Disease, 2021, 12: 20406223211028790.
    [74] ISHIKAWA D, SASAKI T, TAKAHASHI M, KUWAHARA-ARAI K, HAGA K, ITO S, OKAHARA K, NAKAJIMA A, SHIBUYA T, OSADA T, HIRAMATSU K, WATANABE S, NAGAHARA A. The microbial composition of bacteroidetes species in ulcerative colitis is effectively improved by combination therapy with fecal microbiota transplantation and antibiotics[J]. Inflammatory Bowel Diseases, 2018, 24(12): 2590-2598.
    [75] BRETON J, KASTL A, HOFFMANN N, ROGERS R, GROSSMAN AB, MAMULA P, KELSEN JR, BALDASSANO RN, ALBENBERG L. Efficacy of combination antibiotic therapy for refractory pediatric inflammatory bowel disease[J]. Inflammatory Bowel Diseases, 2019, 25(9): 1586-1593.
    [76] KUMARI R, YADAV Y, MISRA R, DAS U, DAS ADHIKARI U, MALAKAR P, DUBEY GP. Emerging frontiers of antibiotics use and their impacts on the human gut microbiome[J]. Microbiological Research, 2022, 263: 127127.
    [77] LIU Y, LI BG, SU YH, ZHAO RX, SONG P, LI H, CUI XH, GAO HM, ZHAI RX, FU XJ, REN X. Potential activity of Traditional Chinese Medicine against Ulcerative colitis: a review[J]. Journal of Ethnopharmacology, 2022, 289: 115084.
    [78] GUO MZ, DING S, ZHAO CH, GU XX, HE XY, HUANG KL, LUO YB, LIANG ZH, TIAN HT, XU WT. Red Ginseng and Semen Coicis can improve the structure of gut microbiota and relieve the symptoms of ulcerative colitis[J]. Journal of Ethnopharmacology, 2015, 162: 7-13.
    [79] LI MX, LI MY, LEI JX, WU YZ, LI ZH, CHEN LM, ZHOU CL, SU JY, HUANG GX, HUANG XQ, ZHENG XB. Huangqin decoction ameliorates DSS-induced ulcerative colitis: role of gut microbiota and amino acid metabolism, mTOR pathway and intestinal epithelial barrire[J]. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, 2022, 100: 154052.
    [80] ZHENG JH, LI H, ZHANG P, YUE SJ, ZHAI BT, ZOU JB, CHENG JX, ZHAO CB, GUO DY, WANG J. Paeonol ameliorates ulcerative colitis in mice by modulating the gut microbiota and metabolites[J]. Metabolites, 2022, 12(10): 956.
    [81] 李云从, 刘星星. 白头翁汤治疗溃疡性结肠炎的作用机制研究进展[J]. 华中科技大学学报(医学版), 2022, 51(2): 267-271. LI YC, LIU XX. Research progress on the mechanism of Pulsatilla decoction in the treatment of ulcerative colitis[J]. Acta Medicinae Universitatis Scientiae et Technologiae Huazhong, 2022, 51(2): 267-271(in Chinese).
    [82] MIAO ZW, CHEN LP, FENG H, GU MJ, YAN J, XU Y, YE B. Baitouweng decoction ameliorates ulcerative colitis in mice partially attributed to regulating Th17/Treg balance and restoring intestinal epithelial barrier[J]. Frontiers in Pharmacology, 2021, 11: 531117.
    [83] KOU FS, SHI L, LI JX, WANG ZB, SHI R, MAO TY, KE X, ZHANG BP, YANG XJ, WEN XL, ZHENG WY, HAN X, DING PH, DONG J. Clinical evaluation of traditional Chinese medicine on mild active ulcerative colitis: a multi-center, randomized, double-blind, controlled trial[J]. Medicine, 2020, 99(35): e21903.
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

YE Mengling, LIU Yang, TANG Leilei, JIANG Guojun. Research progress of intestinal barrier and gut microbiota in ulcerative colitis[J]. Microbiology China, 2024, 51(9): 3384-3397

Copy
Related Videos

Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:December 02,2023
  • Adopted:March 18,2024
  • Online: September 19,2024
  • Published: September 20,2024
Article QR Code
  • WeChat ID
  • Mobile Terminal

Microbiology China ® 2025 All Rights Reserved